DOI:
10.1055/s-00000011
DMW - Deutsche Medizinische Wochenschrift
LinksClose Window
References
Hortobagyi GN, Stemmer SM, Burris HA. et al.
Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer.
N Engl J Med 2016;
375: 1738-1748
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.